- Home
- Healthcare
- Psoriatic Arthritis (PsA) treatment market
Psoriatic Arthritis (PsA) treatment market Size, Share, Growth, and Industry Analysis, By Type (Nonsteriodal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Biologics), By Application (Hospitals, Clinics, Others), and Regional Forecast to 2033
Region: Global | Format: PDF | Report ID: PMI3376 | SKU ID: 28144466 | Pages: 80 | Published : July, 2025 | Base Year: 2024 | Historical Data: 2020-2023
Detailed TOC of Global Psoriatic Arthritis (PsA) Treatment Market Research Report 2025
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nonsteriodal Anti-inflammatory Drugs
1.2.3 Disease Modifying Antirheumatic Drugs
1.2.4 Biologics
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2019-2030)
2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Region
2.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Size by Region (2019-2025)
2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Psoriatic Arthritis (PsA) Treatment Market Dynamics
2.3.1 Psoriatic Arthritis (PsA) Treatment Industry Trends
2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers
2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges
2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue
3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2019-2025)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2019-2025)
3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2023
3.5 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type
4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2019-2025)
4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2025-2030)
5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application
5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2019-2025)
5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
6.2 North America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2025)
6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2025)
7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2019-2025)
8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2025)
9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2025)
10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.3.5 AbbVie Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.4.5 Novartis Recent Development
11.5 UCB
11.5.1 UCB Company Detail
11.5.2 UCB Business Overview
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.5.5 UCB Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.8.5 Eli Lilly Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.9.5 Amgen Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.10.5 AstraZeneca Recent Development
11.11 Celgene
11.11.1 Celgene Company Detail
11.11.2 Celgene Business Overview
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2025)
11.11.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
GET A FREE SAMPLE